A Pilot Study to Measure Plasma and Urinary Prostaglandin D2 Metabolites Evoked by Niacin.

Trial Profile

A Pilot Study to Measure Plasma and Urinary Prostaglandin D2 Metabolites Evoked by Niacin.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 May 2013

At a glance

  • Drugs Niacin (Primary) ; Aspirin
  • Indications Cardiovascular disorders; Lipid metabolism disorders; Musculoskeletal pain; Stroke; Thrombosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 21 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top